Runcaciguat
CAS No. 1402936-61-1
Runcaciguat( —— )
Catalog No. M26816 CAS No. 1402936-61-1
Runcaciguat is a soluble guanylate cyclase stimulator. Runcaciguat combines with selective partial adenosine A1 receptor agonists and can be used in studies about cardiovascular and renal diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 222 | Get Quote |
|
| 10MG | 402 | Get Quote |
|
| 25MG | 665 | Get Quote |
|
| 50MG | 888 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRuncaciguat
-
NoteResearch use only, not for human use.
-
Brief DescriptionRuncaciguat is a soluble guanylate cyclase stimulator. Runcaciguat combines with selective partial adenosine A1 receptor agonists and can be used in studies about cardiovascular and renal diseases.
-
DescriptionRuncaciguat is a soluble guanylate cyclase stimulator. Runcaciguat combines with selective partial adenosine A1 receptor agonists and can be used in studies about cardiovascular and renal diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptormGluR1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1402936-61-1
-
Formula Weight488.33
-
Molecular FormulaC23H22Cl2F3NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (255.97 mM)
-
SMILES[H][C@@]([C@@H](C)C(F)(F)F)(C(=O)Nc1cc(ccc1Cl)[C@@H](CC(O)=O)C1CC1)c1ccc(Cl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yu SP, Sensi SL, et al. Membrane-delimited modulation of NMDA currents by metabotropic glutamate receptor subtypes 1/5 in cultured mouse cortical neurons. J Physiol. 1997 Mar 15;499 ( Pt 3)(Pt 3):721-32.
molnova catalog
related products
-
ASP-9521
ASP-9521 is an effective, specific and orally available AKR1C3 inhibitor (IC50: 11 nM, for human).
-
TAPI 2
ADAM-17 (TACE) and MMP inhibitor (Ki = 120 nM at ADAM-17). Sensitizes cancer stem cells to the lethal effects of 5-FU in vitro. Blocks shedding of TNF-α from cell membranes.
-
β II probe
β II probe
Cart
sales@molnova.com